Enzymatica Names Katja Margell Director of Investor Relations and Corporate Affairs
- Enzymatica appointed Katja Margell director of investor relations and corporate affairs, effective November 1, 2026.
- Her remit covers investor relations, corporate communications and stakeholder relations.
- Margell joins from Duni Group, where she was investor relations and communications director. She previously held communications roles at Hansa Biopharma and SEB.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enzymatica AB published the original content used to generate this news brief on October 27, 2026, and is solely responsible for the information contained therein.